ALK-Abelló (Denmark)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Denmark), Denmark, covering academic research published from 2000 to 2024. Read More.

Open Access Percentage

46%

Total
Publications

848

Total Open
Publications

387

Total
Citations

31K

Open Access
Percentage

46%

Total
Publications

848

Total Open
Publications

387

Total
Citations

31K

Wikipedia

Website

download

Breakdown

Publisher Open

26%

Both

14%

Other Platform Open

Closed

54%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 23%

Hybrid 28%

No Guarantees 49%

165

Other Platform Open

Domain 61%

104

Institution 35%

Other Internet 19%

Public 8%

Preprint 4%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	105
Europe PMC	Domain	47
Semantic Scholar	Public	12
University College London - UCL Discovery	Institution	10
DOI	Other Internet	10
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit	Institution	9
University of Southern Denmark - University of Southern Denmark Research Portal	Institution	8
Taylor and Francis Group - Dove Medical Press	Other Internet	6
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia	Other Internet	6
Unknown Repository	Other Internet	5

1 / 7

Data updated 7 April 2025